January 21st, 2015 · Leave a Comment
From the pages of Mayo Clinic Magazine.
The first thing the Arndts want you to know about them is their strong faith in God. They say it’s gotten them through some very tough times — mother Tara’s two bouts of cancer (one melanoma, one Hodgkin lymphoma); daughter Kelly’s head wound that sent her to the emergency room in an ambulance; and daughter Madison’s fight with H1N1 flu, which had killed several children in their home state of Minnesota that year.
They knew their faith would see them through another trial two years ago, but Mom and Dad were worried. Doctors at Mayo Clinic noticed lesions on Madison’s eye, and the 11-year-old’s vision was getting worse. Her sight had never been great — she’d gotten her first eyeglasses at age 4, starting with a +3 prescription. Then at age 6, local doctors saw scarring on both eyes and referred her to Mayo.
In the years between 6 and 11, Mayo Clinic worked with Madison and her parents, and Madison’s vision remained fairly stable. But these new lesions worried Mayo Clinic ophthalmologist Jose S. Pulido, M.D., as did the inflammation in her eyes.
Mayo Clinic doctors placed a steroid implant, but soon Madison had headaches and blurry vision. Her eye pressures were extremely high at 43 (normal eye pressure ranges from 12 to 22), which Dr. Pulido relieved through a prescription of four eyedrops and a pill. And even though Dr. Pulido was doing everything he and colleagues could to control Madison’s symptoms, the future frightened her family.
“We worried about the unknown,” Tara says. “That was the scary part — is she going to go blind? As a parent, you just want to know what’s wrong. Let’s get this fixed.”
December 31st, 2014 · Leave a Comment
The Mayo Clinic Center for Regenerative Medicine used Mayo Clinic's social media networks to broadcast live to the public the latest from the 10th Annual World Stem Cell Summit. Below you will find a summary of content posted to Facebook, Google+, Twitter, YouTube and Flickr by Mayo Clinic and other attendees of the summit. This content is presented to you in a chronological order, broken down day by day, beginning with "Day 1 of 3" below.
November 29th, 2014 · Leave a Comment
Mayo Clinic Center for Regenerative Medicine to Co-Host the World Stem Cell Summit in San Antonio
The World Stem Cell Summit, December 3-5 in San Antonio, unites and educates the global stem cell community. With more than 1,200 attendees from more than 40 countries, the annual World Stem Cell Summit’s interdisciplinary agenda explores disease updates, research directions, cell standardization, regulatory pathways, reimbursements, financing, venture capital and economic development.
Throughout the week, the Mayo Clinic Center for Regenerative Medicine will use social media to connect using the hashtag #WSCS14. At the end of the week, we'll let the tweets, Google+ posts, Flickr photos, Facebook posts and YouTube videos tell the story. Read the rest of this entry »
November 19th, 2014 · Leave a Comment
The American Heart Association (AHA) awarded the 2014 Basic Research Prize to Andre Terzic, M.D., Ph.D., of Mayo Clinic. The award, presented at the annual meeting of the American Heart Association in Chicago, recognizes outstanding contributions to the advancement of cardiovascular science. Dr. Terzic was commended for pioneering applications of emerging technologies to advance the diagnosis and treatment of cardiovascular diseases.
“In the year when we celebrate the 100th anniversary of the Division of Cardiovascular Diseases at Mayo Clinic, we are particularly proud that one of our own has been recognized with such a prestigious national award,” says Charanjit Rihal, M.D., chair of Mayo's Division of Cardiovascular Diseases. “Dr. Terzic has truly advanced the frontiers of medical science. As a pioneer in cardiac regenerative medicine, he and his team have been at the vanguard of health care.”
“As we look into the future, the pandemic of cardiovascular disease will mandate new solutions, indeed disruptive innovations, to address the unmet needs of patients and populations across the globe,” Dr. Terzic said when he accepted the prize. “The unison of fundamental discovery with clinical translation — and ultimately application to populations — will provide a guiding principle for generations to come.”
October 27th, 2014 · Leave a Comment
Dr. Windebank, professor of neurology and deputy director for discovery in the Mayo Clinic Center for Regenerative Medicine, and Dr. Staff, assistant professor of neurology, are studying the use of mesenchymal stem cells derived from patient adipose (fat) tissue delivered to the spinal fluid of patients with amyotrophic lateral sclerosis (ALS). ALS is often called Lou Gehrig’s disease, after Lou Gehrig, a hall-of-fame baseball player for the New York Yankees who was diagnosed with ALS at Mayo Clinic in 1939.
Watch the presentation, filmed at the Mayo Clinic Research Information Center, below:
New Hope: Stem Cell Trial for ALS Patients
Page loaded in 0.496 seconds